Nicolai Tangen recent buys & sells (2021 Q2)
AKO Capital
AKO Capital Portfolio Changes
Purchase & sale details
- Portfolio value:
- $8.88B (+$787M)
- Previous value:
- $8.09B
- # of changes:
- 28
- New positions:
- 1
- Reported for:
- 30 Jun 2021 (Q2)
- Latest filing date:
- 06 Aug 2021
AKO Capital has disclosed a total of 28 changes to the portfolio in the (2021 Q2) SEC report(s): increased the number of shares of 12, bought 1 totally new, decreased the number of shares of 13 and completely sold out 2 position(s).
What stocks did Nicolai Tangen buy in 2021 Q2?
During 2021 Q2 Nicolai Tangen has bought 13 securities out of which top 5 purchases (by % change to portfolio) were (GOOG) Alphabet Inc, CL-C (added shares +0.70%), (TMO) Thermo Fisher Scientific Inc (added shares +33.78%), (NKE) Nike Inc (added shares +33.36%), (V) Visa Inc, CL-A (added shares +0.70%) and (ZTS) Zoetis Inc (added shares +52.87%).
In the 2021 Q2 report(s) the following changes have been made to the top investments: (LIN) Linde plc Ordinary Shares (reduced shares -0.93%), (BKNG) Booking Holdings Inc (reduced shares -11.11%), (GOOG) Alphabet Inc, CL-C (added shares +0.70%), (EBAY) eBay Inc (reduced shares -22.92%) and (TMO) Thermo Fisher Scientific Inc (added shares +33.78%).
28 results
| History | Ticker | Name |
% or activity |
Shares change |
Shares held after* |
% change to portfolio |
Reported price* |
% difference current price* |
% of portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Pinterest Inc
|
new
|
+1,553,499
|
1,553,499
|
+1.38%
|
$78.95
|
-71.34%($22.63)
|
1.38%
|
2021 Q2
|
~0.25 years
|
|
|
|
Equifax Inc
|
+197.17%
|
+904,198
|
1,362,775
|
+2.44%
|
$239.51
|
-23.63%($182.92)
|
3.68%
|
2021 Q1
|
~0.50 years
|
|
|
|
Diageo PLC ADR
|
+71.23%
|
+533,371
|
1,282,189
|
+1.15%
|
$191.69
|
-50.16%($95.54)
|
2.77%
|
2021 Q1
|
~0.50 years
|
|
|
|
Zoetis Inc
|
+52.87%
|
+841,224
|
2,432,203
|
+1.77%
|
$186.36
|
-56.58%($80.92)
|
5.11%
|
2019 Q2
|
~2.25 years
|
|
|
|
Core Laboratories NV
|
+34.19%
|
+347,797
|
1,365,005
|
+0.15%
|
$38.95
|
-74.71%($9.85)
|
0.60%
|
2020 Q2
|
~1.25 years
|
|
|
|
Thermo Fisher Scientific Inc
|
+33.78%
|
+248,578
|
984,437
|
+1.41%
|
$504.47
|
+32.71%($669.50)
|
5.60%
|
2020 Q3
|
~1.00 year
|
|
|
|
Nike Inc
|
+33.36%
|
+798,909
|
3,193,614
|
+1.39%
|
$154.49
|
-75.73%($37.49)
|
5.56%
|
2016 Q4
|
~4.75 years
|
|
|
|
Moodys Corp
|
+26.05%
|
+197,134
|
953,868
|
+0.8%
|
$362.37
|
+32.83%($481.33)
|
3.89%
|
2016 Q4
|
~4.75 years
|
|
|
|
Visa Inc, CL-A
|
+0.70%
|
+13,891
|
1,986,005
|
+0.04%
|
$233.82
|
+74.81%($408.74)
|
5.23%
|
2016 Q4
|
~4.75 years
|
|
|
|
Ambev SA ADR
|
+0.70%
|
+230,876
|
33,058,851
|
+0.01%
|
$3.44
|
-3.63%($3.32)
|
1.28%
|
2017 Q3
|
~4.00 years
|
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted. 2013 Q2 is the earliest period we have data for, so "2013 Q2*" means "2013 Q2 or earlier".